Life Molecular Imaging, Sofie add Neuraceq availability out of Ohio
AuntMinnie
APRIL 4, 2024
for the detection of beta-amyloid plaques in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline, according to the vendor. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.
Let's personalize your content